Khutaija Noor, MBBS, FCR If you are looking into a clinical trial for a condition like depression, the paperwork can feel like a riddle. The researchers say they need people who are currently struggling with symptoms, but then they ask: " Is your heart healthy? Are your kidneys working well? Have you stayed out of the hospital lately? " It feels like a contradiction. You might think, " I’m here because I’m not okay- so why do I need to be 'stable' in everything else ?" After

Khutaija Noor, MBBS, FCR For years, many people saw clinical trials as a desperate "last resort," something only considered when all standard treatments for therapeutic illnesses had failed. That outdated perception is rapidly changing. Today, more individuals across the United States are exploring clinical trials much earlier in their health journey. They're seeking not just access to new therapies, but also the enhanced care and deep engagement that come with the research p

Khutaija Noor, MBBS, FCR Have you ever wondered why a medicine that works wonders for one person might not be as effective for another? It's a common and important question, and the answer often lies in something deeper than just a person's age or weight. It’s about who we are, where we come from, and the unique biology we each possess. This is a problem the medical community is actively working to solve, and it's a primary reason why diversity in clinical trials is so crucia

Khutaija Noor, MBBS, FCR Are you considering joining a clinical trial?  At Amicis Clinical Trials , we understand that stepping into the world of clinical research can raise important questions. Participating in a clinical study is a meaningful decision that contributes to advancing medical science, and your comfort and understanding are essential. To help you make an informed choice, here are the top five most frequently asked questions by patients —clearly answered by our r

Khutaija Noor, MBBS, FCR A New Era in Diabetes Care Managing Type 2 Diabetes Mellitus (T2DM) has long been a challenge for both patients and physicians (1) . While traditional treatments such as oral medications and insulin therapy have been the mainstay, they often come with significant drawbacks, including weight gain, increased cardiovascular risks, and complex dosing schedules (2) . In recent years, a newer class of medications has emerged, offering a more effective and p